Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
7.74    -0.41 (-5.03%)
Bid:
7.74
Ask:
8.04
Spread: 0.30 (3.876%)
Market Cap: £89.46m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Directorate Changes

8 Mar 2023 07:01

RNS Number : 2200S
SIG PLC
08 March 2023
 

LEI: 213800VDC1BKJEZ8PV53 8 March 2023

 

SIG plc (the "Company" or "SIG")

Directorate changes

SIG announces that Christian Rochat, one of the two Directors appointed by CD&R Sunshine S.À R.L ("CD&R"), informed the Company yesterday that he does not intend to stand for re-election at the Annual General Meeting on 4 May 2023 (the "AGM"). CD&R yesterday served notice on the Company that it intends to nominate Mr Diego Straziota for appointment to SIG's Board at the AGM.

 

Mr Straziota is a Managing Director at CD&R principally engaged in evaluating investment opportunities in the industrials and business services verticals. He has served as CD&R's appointed observer to SIG's Audit & Risk Committee since July 2020. There are no disclosures required in respect of this appointment pursuant to Listing Rule 9.6.13 (1) to (6).

 

Commenting on these changes, SIG's Chairman Andrew Allner said "Christian joined the Board at the time of CD&R's investment in July 2020. We are grateful to him for the contribution he has made to the Company's turnaround and progress since then, to the benefit of all of SIG's shareholders. Diego is well-known to the Board, and we look forward to working with him."

 

 

SIG plc

 

+44 (0) 114 285 6300

Andrew Allner

Chairman

FTI Consulting

 

+44 (0) 20 3727 1340

Richard Mountain

Peel Hunt LLP - Joint broker to SIG

+44 (0) 20 7418 8900

Mike Bell / Charles Batten

 

 

Investec Bank plc - Joint broker to SIG

+44 (0) 20 7597 5970

Bruce Garrow / David Anderson

 

Notes

· There are no remuneration payments (within the meaning of section 430(2B) of the Companies Act 2006) that will be paid to Christian Rochat following him ceasing to be a director and he will not receive any payment for loss of office

 

· Under the terms of the relationship agreement dated 29 May 2020 between the Company and CD&R, whilst CD&R holds at least 20% of the votes able to be cast at general meetings of the Company, CD&R has the right to appoint two non-executive directors to the Board (each a "Nominee Director"). In addition, whilst CD&R holds at least 10% of the votes able to be cast at general meetings of the Company, CD&R has the right to designate a Nominee Director to sit on each of the Remuneration Committee and the Nominations Committee, and to appoint an observer to the Audit & Risk Committee

 

· Christian Rochat is a member of the Nominations Committee. Upon him ceasing to be a director, CD&R's other current Nominee Director, Bruno Deschamps, shall be appointed a member of the Nominations Committee. Bruno will remain a member of the Remuneration Committee

 

· Diego Straziota shall continue to be CD&R's appointed observer to the Audit & Risk Committee following his appointment as a Nominee Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADDGDXUGGDGXR
Date   Source Headline
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding
8th Apr 20223:28 pmRNSDirector/PDMR Shareholding
8th Apr 20223:25 pmRNSDirector/PDMR Shareholding
28th Mar 20223:14 pmRNSNotice of AGM
16th Mar 202212:24 pmRNSDirector/PDMR Shareholding
15th Mar 20224:41 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNSAnnual Financial Report
11th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
7th Mar 20224:16 pmRNSHolding(s) in Company
11th Jan 20227:00 amRNSFull Year Trading Update
17th Dec 20214:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSTrading Update
13th Dec 202111:15 amRNSDirector/PDMR Shareholding
2nd Dec 20212:54 pmRNSDirector/PDMR Shareholding
30th Nov 20213:28 pmRNSDirector/PDMR Shareholding
12th Nov 202112:16 pmRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSPricing of EUR300,000,000 Senior Secured Notes
2nd Nov 20211:38 pmRNSPre Stabilisation Notice
1st Nov 20217:52 amRNSProposed Refinancing Transactions
22nd Oct 20217:00 amRNSTrading Statement
6th Oct 20214:54 pmRNSDirector/PDMR Shareholding
21st Sep 20217:00 amRNSResults for the 6 months to 30 June 2021
14th Jul 20217:00 amRNSTrading Update
16th Jun 202110:59 amRNSShare Capital Reduction Confirmation
14th May 20212:51 pmRNSDirectorate Change
13th May 20214:18 pmRNSNotice of Results
5th May 20217:00 amRNSTrading Statement
12th Apr 20214:54 pmRNSDirector/PDMR Shareholding amendment
12th Apr 202112:51 pmRNSDirector/PDMR Shareholding
8th Apr 20219:04 amRNS2020 Annual Report & Accounts and Notice of AGM
31st Mar 20219:11 amRNSDirector/PDMR Shareholding
31st Mar 20219:05 amRNSDirector/PDMR Shareholding
31st Mar 20219:03 amRNSDirector/PDMR Shareholding
25th Mar 20217:00 amRNSFull year results
2nd Mar 20217:00 amRNSNotice of 2020 Full Year Results
28th Jan 20219:00 amRNSAppointment of new Non-Executive Director
11th Jan 20217:00 amRNSFull Year Trading Update
18th Dec 202012:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.